Todd P. Branning
2020 - Phathom Pharmaceuticals
In 2020, Todd P. Branning earned a total compensation of $2M as Chief Financial Officer at Phathom Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $99,829 |
|---|---|
| Option Awards | $1,456,339 |
| Salary | $190,561 |
| Stock Awards | $294,300 |
| Other | $6,375 |
| Total | $2,047,404 |
Branning received $1.5M in option awards, accounting for 71% of the total pay in 2020.
Branning also received $99.8K in non-equity incentive plan, $190.6K in salary, $294.3K in stock awards and $6.4K in other compensation.
Rankings
In 2020, Todd P. Branning's compensation ranked 5,394th out of 13,090 executives tracked by ExecPay. In other words, Branning earned more than 58.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,394 out of 13,090 | 59th |
Division Manufacturing | 2,224 out of 5,621 | 60th |
Major group Chemicals And Allied Products | 888 out of 2,254 | 61st |
Industry group Drugs | 766 out of 1,954 | 61st |
Industry Pharmaceutical Preparations | 573 out of 1,459 | 61st |
Source: SEC filing on April 6, 2021.
Branning's colleagues
We found two more compensation records of executives who worked with Todd P. Branning at Phathom Pharmaceuticals in 2020.